These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 22841231
21. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors. Challine D, Chevaliez S, Pawlotsky JM. Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749 [Abstract] [Full Text] [Related]
22. Older living donors provide excellent quality kidneys: a single center experience (older living donors). Johnson SR, Khwaja K, Pavlakis M, Monaco AP, Hanto DW. Clin Transplant; 2005 Oct; 19(5):600-6. PubMed ID: 16146550 [Abstract] [Full Text] [Related]
23. Response to vaccination against hepatitis B virus with a schedule of four 40-μg doses in cirrhotic patients evaluated for liver transplantation: factors associated with a response. Gutierrez Domingo I, Pascasio Acevedo JM, Alcalde Vargas A, Ramos Cuadra A, Ferrer Ríos MT, Sousa Martin JM, Sayago Mota M, Giráldez Gallego A, Suárez Artacho G. Transplant Proc; 2012 Oct; 44(6):1499-501. PubMed ID: 22841195 [Abstract] [Full Text] [Related]
24. Kidney transplantation in the United States. Cecka JM. Clin Transpl; 2008 Oct; ():1-18. PubMed ID: 19711510 [Abstract] [Full Text] [Related]
25. Challenges in containing the burden of hepatitis B infection in dialysis and transplant patients in India. Potsangbam G, Yadav A, Chandel N, Rathi M, Sharma A, Kohli HS, Gupta KL, Minz M, Sakhuja V, Jha V. Nephrology (Carlton); 2011 May; 16(4):383-8. PubMed ID: 21114569 [Abstract] [Full Text] [Related]
26. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group. Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857 [Abstract] [Full Text] [Related]
27. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, Su J, Sun CA, Liaw YF, Chen CJ, Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL-HBV) Study Group. Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048 [Abstract] [Full Text] [Related]
28. Kidney transplantation from older donors. Di Cocco P, Orlando G, Rizza V, De Luca L, D'Angelo M, Clemente K, Famulari A, Pisani F. Transplant Proc; 2011 May; 43(4):1033-5. PubMed ID: 21620045 [Abstract] [Full Text] [Related]
29. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients. Veroux M, Puliatti C, Gagliano M, Cappello D, Macarone M, Vizcarra D, Spataro M, Di Mare M, Ginevra N, Veroux P. Transplant Proc; 2005 May; 37(6):2574-5. PubMed ID: 16182748 [Abstract] [Full Text] [Related]
30. Is it appropriate to implant kidneys from elderly donors in young recipients? Solá R, Guirado L, López-Navidad A, Bonfill X, Díaz JM, Puig T, Facundo C. Transplantation; 2010 Aug 15; 90(3):286-91. PubMed ID: 20571467 [Abstract] [Full Text] [Related]
31. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation. Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR. Liver Transpl; 2009 Dec 15; 15(12):1776-82. PubMed ID: 19938139 [Abstract] [Full Text] [Related]
32. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J. Liver Transpl; 2001 Jan 15; 7(1):51-8. PubMed ID: 11150423 [Abstract] [Full Text] [Related]
33. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry. Freitas MC. Clin Transpl; 2011 Jan 15; ():1-16. PubMed ID: 22755397 [Abstract] [Full Text] [Related]
34. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH. J Pediatr Gastroenterol Nutr; 2009 Feb 15; 48(2):203-8. PubMed ID: 19179883 [Abstract] [Full Text] [Related]
35. Outcomes of pediatric ABO-incompatible kidney transplantations are equivalent to ABO-compatible controls. Shishido S, Hyodo YY, Aoki Y, Takasu J, Kawamura T, Sakai KK, Aikawa AA, Satou H, Muramatsu MM, Matsui Z. Transplant Proc; 2012 Jan 15; 44(1):214-6. PubMed ID: 22310617 [Abstract] [Full Text] [Related]
36. Long-term outcomes of living kidney donors over the past 28 years in a single center in Taiwan. Tsai SF, Shu KH, Ho HC, Wu MJ, Cheng CH, Lian JD, Wen MC, Su CK, Yu TM, Chuang YW, Huang ST, Chen CH. Transplant Proc; 2012 Jan 15; 44(1):39-42. PubMed ID: 22310573 [Abstract] [Full Text] [Related]
37. Clinical significance of slow recovery of graft function in living donor kidney transplantation. Lee SY, Chung BH, Piao SG, Kang SH, Hyoung BJ, Jeon YJ, Hwang HS, Yoon HE, Choi BS, Kim JI, Moon IS, Kim YS, Choi YJ, Yang CW. Transplantation; 2010 Jul 15; 90(1):38-43. PubMed ID: 20531075 [Abstract] [Full Text] [Related]
38. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Transfusion; 2012 Feb 15; 52(2):440-6. PubMed ID: 21810101 [Abstract] [Full Text] [Related]
39. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients. Huo TI, Yang WC, Wu JC, King KL, Loong CC, Lin CY, Lui WY, Chang FY, Lee SD. Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb 15; 63(2):93-100. PubMed ID: 10677918 [Abstract] [Full Text] [Related]
40. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma. Wu JM, Huang YH, Lee PC, Lin HC, Lee SD. J Clin Gastroenterol; 2009 Feb 15; 43(5):496-8. PubMed ID: 19247200 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]